Poland· PL-100459976
Regkirona
A regdanvimab product containing regdanvimabum, registered in Poland by Celltrion Healthcare Hungary Kft.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Regdanvimab is registered in 6 of 19 countries.
Countries holding a registration under ATC J06BD06 (regdanvimab), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Regdanvimab · ATC J06BD06
6 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Regdanvimabum
- Manufacturer
- Celltrion Healthcare Hungary Kft.
- Country
- Poland (PL)
- ATC code
- J06BD06
- ATC class
- Regdanvimab
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Regdanvimab in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRegkirona 60 mg/mlCelltrion Healthcare Hungary
- DenmarkRegkironaCelltrion Healthcare Hungary Kft
- FinlandRegkironaCelltrion Healthcare Hungary Kft.
- SpainREGKIRONA 60 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONCelltrion Healthcare Hungary Kft.
- United KingdomRegkirona 960mg/16ml concentrate for solution for infusion vialsCelltrion Healthcare UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be4c67d1-113b-44c5-80da-f3f732832de6 GET /v1/drugs/be4c67d1-113b-44c5-80da-f3f732832de6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "60 mg/ml",
"packaging": "Rp ¦ EU/1/21/1597/001 ¦ 142398\n1 fiol. 16 ml",
"substance": "Regdanvimabum 60 mg/ml",
"common_name": "Regdanvimabum",
"pl_product_id": "100459976",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": "2025-04-14"
}See everything about regdanvimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.